Susquehanna International Group
CRBU icon

Susquehanna International Group’s Caribou Biosciences CRBU Stock Holding History

Susquehanna International Group’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$91.6K Buy
48,200
+4,800
+11% +$8.24K ﹤0.01% 12398
2025
Q4 		$69K Buy
43,400
+23,900
+123% +$50.2K ﹤0.01% 11634
2025
Q3 		$45.4K Buy
19,500
+5,200
+36% +$9.82K ﹤0.01% 11892
2025
Q2 		$18K Sell
14,300
-15,000
-51% -$14.8K ﹤0.01% 12351
2025
Q1 		$26.7K Buy
29,300
+300
+1% +$390 ﹤0.01% 12045
2024
Q4 		$46.1K Buy
+29,000
New +$58.3K ﹤0.01% 11713
2024
Q3 		– Sell
-19,400
Closed -$31.8K – 12116
2024
Q2 		$31.8K Sell
19,400
-52,800
-73% -$169K ﹤0.01% 11547
2024
Q1 		$371K Buy
72,200
+42,600
+144% +$263K ﹤0.01% 9208
2023
Q4 		$170K Sell
29,600
-34,300
-54% -$170K ﹤0.01% 10851
2023
Q3 		$305K Buy
+63,900
New +$396K ﹤0.01% 9305
2022
Q4 		– Sell
-33,500
Closed -$353K – 12577
2022
Q3 		$353K Buy
33,500
+6,600
+25% +$61.5K ﹤0.01% 9380
2022
Q2 		$146K Buy
+26,900
New +$206K ﹤0.01% 11053
2022
Q1 		– Sell
-39,900
Closed -$602K – 13094
2021
Q4 		$602K Buy
+39,900
New +$776K ﹤0.01% 8669

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Susquehanna International Group's CRBU Position: Q1 2026 in Review

Susquehanna International Group reduced its Caribou Biosciences (CRBU) stake by 19% in Q1 2026, selling an estimated $334K and leaving 836,903 shares worth $1.59M. The position accounts for ﹤0.01% of the portfolio, ranked #6711.

Susquehanna International Group first reported a position in CRBU in Q4 2021 and has held it in 17 quarters since. The position peaked at $1.64M in Q4 2025. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • Susquehanna International Group held 836,903 shares of Caribou Biosciences worth $1.59M as of Q1 2026.
  • Susquehanna International Group sold 194,472 Caribou Biosciences shares in Q1 2026, an estimated $334K.
  • Caribou Biosciences made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #6711 holding.
  • Susquehanna International Group first reported a position in Caribou Biosciences in Q4 2021 and has held it in 17 quarters since.
  • Susquehanna International Group's Caribou Biosciences position peaked at $1.64M in Q4 2025.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.